2-Piperazineacetonitrile, 4-[7-(3-methoxy-1-naphthalenyl)-2-[[(2S)-1-methyl-2-pyrrolidinyl]methoxy]pyrido[2,3-d]pyrimidin-4-yl]-1-(1-oxo-2-propen-1-yl)-, (2S)-

2-Piperazineacetonitrile, 4-[7-(3-methoxy-1-naphthalenyl)-2-[[(2S)-1-methyl-2-pyrrolidinyl]methoxy]pyrido[2,3-d]pyrimidin-4-yl]-1-(1-oxo-2-propen-1-yl)-, (2S)- Basic information
Product Name:2-Piperazineacetonitrile, 4-[7-(3-methoxy-1-naphthalenyl)-2-[[(2S)-1-methyl-2-pyrrolidinyl]methoxy]pyrido[2,3-d]pyrimidin-4-yl]-1-(1-oxo-2-propen-1-yl)-, (2S)-
Synonyms:2-Piperazineacetonitrile, 4-[7-(3-methoxy-1-naphthalenyl)-2-[[(2S)-1-methyl-2-pyrrolidinyl]methoxy]pyrido[2,3-d]pyrimidin-4-yl]-1-(1-oxo-2-propen-1-yl)-, (2S)-;KRAS G12C inhibitor 43
CAS:2648808-69-7
MF:C33H35N7O3
MW:577.68
EINECS:
Product Categories:
Mol File:2648808-69-7.mol
2-Piperazineacetonitrile, 4-[7-(3-methoxy-1-naphthalenyl)-2-[[(2S)-1-methyl-2-pyrrolidinyl]methoxy]pyrido[2,3-d]pyrimidin-4-yl]-1-(1-oxo-2-propen-1-yl)-, (2S)- Structure
2-Piperazineacetonitrile, 4-[7-(3-methoxy-1-naphthalenyl)-2-[[(2S)-1-methyl-2-pyrrolidinyl]methoxy]pyrido[2,3-d]pyrimidin-4-yl]-1-(1-oxo-2-propen-1-yl)-, (2S)- Chemical Properties
Boiling point 820.2±75.0 °C(Predicted)
density 1.246±0.06 g/cm3(Predicted)
pka9.17±0.40(Predicted)
Safety Information
MSDS Information
2-Piperazineacetonitrile, 4-[7-(3-methoxy-1-naphthalenyl)-2-[[(2S)-1-methyl-2-pyrrolidinyl]methoxy]pyrido[2,3-d]pyrimidin-4-yl]-1-(1-oxo-2-propen-1-yl)-, (2S)- Usage And Synthesis
UsesKRAS G12C inhibitor 43 (compound 59) is a potent KRAS G12C inhibitor. KRAS G12C inhibitor 43 shows antimigration and anti-proliferative activity with IC50s of 0.001-1 μM, >1 μM, >1 μM for H358, A549, HCC cells ,respectively[1].
IC 50KRas G12C
References[1] Xu Wei, et al. Pyridopyrimidine kras g12c mutant protein inhibitor. WO2021139678A1.
2-Piperazineacetonitrile, 4-[7-(3-methoxy-1-naphthalenyl)-2-[[(2S)-1-methyl-2-pyrrolidinyl]methoxy]pyrido[2,3-d]pyrimidin-4-yl]-1-(1-oxo-2-propen-1-yl)-, (2S)- Preparation Products And Raw materials
Tag:2-Piperazineacetonitrile, 4-[7-(3-methoxy-1-naphthalenyl)-2-[[(2S)-1-methyl-2-pyrrolidinyl]methoxy]pyrido[2,3-d]pyrimidin-4-yl]-1-(1-oxo-2-propen-1-yl)-, (2S)-(2648808-69-7) Related Product Information
2-Propen-1-one, 1-[(3S)-4-[(7R)-7-[6-amino-4-methyl-3-(trifluoromethyl)-2-pyridinyl]-6-chloro-8-fluoro-2-[[(2S)-1-methyl-2-pyrrolidinyl]methoxy]-4-quinazolinyl]-3-methyl-1-piperazinyl]- 2,7-Diazaspiro[4.4]nonane-2-acetamide, α-cyclopentyl-7-[[(2R,3R)-3-cyclopropyl-1-methyl-2-aziridinyl]carbonyl]-N-[(1R,10S,12S,18S)-1-[5-(4-cyclopropyl-1-piperazinyl)-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-2,7,8,10,11,12,13,16,17,18,19,21,22,23-tetradecahydro-22,22-dimethyl-13,19-dioxo-2-(2,2,2-trifluoroethyl)-15H-3,5-etheno-14,18-imino-6,10-methano-6H-pyrrolo[3,4-g][1,12,4,18]dioxadiazacyclodocosin-12-yl]-, (αS,5S)- NAV2729 Y-27632 1,4-Oxazepin-5(2H)-one, 4-[3-[[2-[[2-ethyl-4-(4-methyl-1-piperazinyl)phenyl]amino]-5-(trifluoromethyl)-4-pyrimidinyl]amino]propyl]tetrahydro- RMC-7977